Dirk Woitalla

9.7k total citations
112 papers, 3.8k citations indexed

About

Dirk Woitalla is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Dirk Woitalla has authored 112 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Neurology, 26 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in Dirk Woitalla's work include Parkinson's Disease Mechanisms and Treatments (77 papers), Neurological disorders and treatments (35 papers) and Genetic Neurodegenerative Diseases (11 papers). Dirk Woitalla is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (77 papers), Neurological disorders and treatments (35 papers) and Genetic Neurodegenerative Diseases (11 papers). Dirk Woitalla collaborates with scholars based in Germany, United States and Switzerland. Dirk Woitalla's co-authors include W. Kuhn, Thomas Müller, H. Przuntek, Rejko Krüger, Siegfried Muhlack, Oliver Goetze, Olaf Rieß, Daniela Berg, Lüdger Schöls and Wolfgang E. Schmidt and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Dirk Woitalla

107 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Woitalla Germany 32 2.3k 993 944 556 503 112 3.8k
Ruth Djaldetti Israel 36 3.0k 1.3× 1.2k 1.2× 760 0.8× 598 1.1× 512 1.0× 129 4.7k
Miho Murata Japan 37 2.4k 1.0× 1.6k 1.6× 1.4k 1.5× 698 1.3× 509 1.0× 164 4.8k
Tomoyoshi Kondo Japan 34 2.2k 1.0× 1.4k 1.4× 954 1.0× 388 0.7× 461 0.9× 132 3.7k
W. Kuhn Germany 33 2.3k 1.0× 1.2k 1.2× 1.3k 1.4× 596 1.1× 758 1.5× 113 4.4k
Lars Forsgren Sweden 41 3.2k 1.4× 940 0.9× 1.0k 1.1× 985 1.8× 721 1.4× 101 4.9k
Taku Hatano Japan 35 2.3k 1.0× 718 0.7× 1.1k 1.1× 684 1.2× 444 0.9× 149 3.9k
Yih‐Ru Wu Taiwan 34 2.1k 0.9× 1.5k 1.5× 1.9k 2.1× 809 1.5× 707 1.4× 218 4.9k
Jifeng Guo China 33 1.8k 0.8× 1.0k 1.0× 1.6k 1.7× 725 1.3× 716 1.4× 224 3.9k
Cheryl Waters United States 39 3.7k 1.6× 1.3k 1.3× 649 0.7× 1.0k 1.9× 624 1.2× 107 5.0k
Carlos Singer United States 32 2.8k 1.2× 1.1k 1.1× 391 0.4× 400 0.7× 291 0.6× 134 3.8k

Countries citing papers authored by Dirk Woitalla

Since Specialization
Citations

This map shows the geographic impact of Dirk Woitalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Woitalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Woitalla more than expected).

Fields of papers citing papers by Dirk Woitalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Woitalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Woitalla. The network helps show where Dirk Woitalla may publish in the future.

Co-authorship network of co-authors of Dirk Woitalla

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Woitalla. A scholar is included among the top collaborators of Dirk Woitalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Woitalla. Dirk Woitalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woitalla, Dirk, Anca M. Miron, Kanjana Unnwongse, et al.. (2025). Multimodal tele-epileptology: Challenges on the way to interoperable medical data. Clinical Neurophysiology Practice. 10. 56–62.
3.
Jost, Wolfgang H., Carsten Buhmann, Joseph Claßen, et al.. (2022). Stellenwert der COMT-Hemmer in der Therapie motorischer Fluktuationen. Der Nervenarzt. 93(10). 1035–1045. 5 indexed citations
4.
Bartig, Dirk, Lennard Herrmann, Gesine Respondek, et al.. (2020). Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017. Journal of Clinical Medicine. 9(8). 2454–2454. 4 indexed citations
5.
Pesch, Beate, Swaantje Casjens, Dirk Woitalla, et al.. (2019). Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease. Cells. 8(2). 96–96. 28 indexed citations
6.
Casjens, Swaantje, Shalmali Dharmadhikari, Anne Lotz, et al.. (2018). Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study. PMC. 2 indexed citations
7.
Richter, Daniel, Dirk Woitalla, Siegfried Muhlack, et al.. (2018). Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients. Frontiers in Neurology. 9. 645–645. 16 indexed citations
8.
Pesch, Beate, Ulrike Dydak, Anne Lotz, et al.. (2017). Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study. NeuroToxicology. 64. 68–77. 14 indexed citations
9.
Henkel, Sebastian, et al.. (2015). Epitope Mapping Using Peptide Microarray in Autoantibody Profiling. Methods in molecular biology. 1368. 209–224. 4 indexed citations
10.
Schreglmann, Sebastian R., et al.. (2015). Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal. Journal of Neurology. 262(8). 1946–1953. 10 indexed citations
11.
Kerasnoudis, Antonios, et al.. (2014). Sarcoid neuropathy: Correlation of nerve ultrasound, electrophysiological and clinical findings. Journal of the Neurological Sciences. 347(1-2). 129–136. 24 indexed citations
12.
Turewicz, Michael, Caroline May, Maike Ahrens, et al.. (2013). Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArrays. PROTEOMICS. 13(14). 2083–2087. 15 indexed citations
14.
Ahrens, Maike, Michael Turewicz, Swaantje Casjens, et al.. (2013). Detection of Patient Subgroups with Differential Expression in Omics Data: A Comprehensive Comparison of Univariate Measures. PLoS ONE. 8(11). e79380–e79380. 5 indexed citations
15.
Saft, Carsten, et al.. (2011). No evidence of impaired gastric emptying in early Huntington‘s Disease. PLoS Currents. 3. RRN1284–RRN1284. 2 indexed citations
16.
Müller, Thomas, et al.. (2008). Catechol-O-methyltransferase Inhibition Improves Levodopa-Associated Strength Increase in Patients With Parkinson Disease. Clinical Neuropharmacology. 31(3). 134–140. 10 indexed citations
17.
Woitalla, Dirk, et al.. (2007). The Management Approaches to Dyskinesia Vary from Country to Country. Neuroepidemiology. 29(3-4). 163–169. 6 indexed citations
18.
Woitalla, Dirk, et al.. (2004). Transdermal lisuride delivery in the treatment of Parkinson’s disease. Journal of neural transmission. Supplementum. 89–95. 26 indexed citations
19.
Krüger, Rejko, Christian Fischer, Thorsten Schulte, et al.. (2003). Mutation analysis of the neurofilament M gene in Parkinson's disease. Neuroscience Letters. 351(2). 125–129. 24 indexed citations
20.
Müller, Thomas, Dirk Woitalla, David W. Schulz, et al.. (2000). Tolcapone increases maximum concentration of levodopa. Journal of Neural Transmission. 107(1). 113–119. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026